1
|
Li K, Mi L, Bai X, Lu Y, Zhang Y, Li J, Pu Y. Induction of apoptosis and autophagy by dichloromethane extract from Patrinia scabiosaefolia Fisch on acute myeloid leukemia cells. ENVIRONMENTAL TOXICOLOGY 2024; 39:2123-2137. [PMID: 38108539 DOI: 10.1002/tox.24090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2023] [Revised: 10/26/2023] [Accepted: 12/01/2023] [Indexed: 12/19/2023]
Abstract
Patrinia scabiosaefolia Fisch (PS), a perennial herb belonging to the genus Pinus in the family Pinnacle Sauce, has been previously known for its analgesic, anti-inflammatory, antibacterial, and antitumor properties. However, the specific mechanism behind its antileukemic effect remains unknown. This study focused on the cytotoxicity and potential modes of action of the dichloromethane extract from PS (DEPS) in acute myeloid leukemia (AML) cells. Our results demonstrated that DEPS reduced cell viability, arrested the cell cycle in the G2/M phase, disrupted the mitochondrial membrane potential, increased reactive oxygen species (ROS) production, and upregulated the expression of Bax/Bcl-2 and Cleaved caspase-3. However, the impact of DEPS on cell viability and the expression of apoptosis-associated proteins was reversed upon pretreatment with the caspase-3 inhibitor (Z-DEVD-FMK) in HL-60 cells, which demonstrated that DEPS could induce apoptosis through the mitochondria-associated apoptotic pathway. Interestingly, DEPS also influenced autophagy by upregulating the expression of LC3II/I, P62, and Beclin-1 proteins, and the autophagy inhibition chloroquine(CQ) could attenuate the apoptotic effects of DEPS in HL-60 cells. Furthermore, SMART 2.0 analysis predicted that the main components present in DEPS were likely terpenoids. In conclusion, DEPS possibly exerts antileukemic effects by downregulating the PI3K/AKT and ERK pathways, thereby promoting intracellular ROS production, activating the mitochondrial apoptotic pathway, and affecting autophagy, providing valuable insights for the potential future application of PS in the treatment of AML.
Collapse
Affiliation(s)
- Kejing Li
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Leyuan Mi
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Clinical Laboratory Center, Gansu Provincial Maternity and Child-Care Hospital (Gansu Provincial Hospital), Lanzhou, Gansu, China
| | - Xinyi Bai
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Yuan Lu
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Ying Zhang
- Central Laboratory, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, Gansu, China
| | - Juan Li
- Central Laboratory, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou, Gansu, China
| | - Yudong Pu
- Precision Medicine Center of the Songshan Lake (SSL) Central Hospital of Dongguan City, Dongguan, Guangdong, China
| |
Collapse
|
2
|
Fu L, Li S, Men X, Cai X, Wang Z, Xu Y, Ren Z, Shao Y, Zhu Y. Optimizing the Extraction and Enrichment of Luteolin from Patrinia villosa and Its Anti-Pseudorabies Virus Activity. Molecules 2023; 28:5005. [PMID: 37446667 DOI: 10.3390/molecules28135005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2023] [Revised: 06/13/2023] [Accepted: 06/22/2023] [Indexed: 07/15/2023] Open
Abstract
Luteolin from Patrinia villosa exhibits strong antiviral activity. Here, the conditions for extracting and enriching luteolin from P. villosa were optimized. Response surface methodology was used to determine the optimal extraction parameters in terms of reflux time, solvent ratio, extraction temperature, material-to-liquid ratio, and number of extractions. Thereafter, a macroporous resin method was used to enrich luteolin from P. villosa. Finally, the following optimal extraction and enrichment conditions were established: an extraction time of 43.00 min, a methanol/hydrochloric acid solvent ratio of 13:1, an extraction temperature of 77.60 °C, a material/liquid ratio of 1:22, and a total of two extractions. NKA-9 was determined to be the most appropriate resin for enrichment. The ideal adsorption conditions were as follows: a pH of 5.0, a temperature of 25 °C, an initial luteolin concentration of 19.58 µg/mL, a sample loading volume of 2.9 BV, and a sample loading rate of 2 BV/h. The ideal desorption conditions were as follows: distilled water, 30% ethanol and 80% ethanol elution, and 5 BV at a flow rate of 2 BV/h. After optimization, the enrichment recovery rate was 80.06% and the luteolin content increased 3.8-fold. Additionally, the enriched product exhibited a significant inhibitory effect on PRV (Porcine pseudorabies virus) in vitro and in vivo, providing data for developing and applying luteolin from P. villosa.
Collapse
Affiliation(s)
- Lian Fu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Su Li
- College of Resources and Environment, Northeast Agricultural University, Harbin 150038, China
| | - Xiaoyu Men
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Xiaojing Cai
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Zhiying Wang
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Yongkang Xu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Zhiyuan Ren
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Yi Shao
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| | - Yan Zhu
- College of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China
| |
Collapse
|
3
|
Sun S, Fu J, Liu K, Dai M, Li Y, Liu Y, Ma S, Qu J. Two New Iridoid Glucosides from the Whole Plant of Patrinia scabiosifolia Link. Molecules 2021; 26:molecules26144201. [PMID: 34299477 PMCID: PMC8304010 DOI: 10.3390/molecules26144201] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2021] [Revised: 07/06/2021] [Accepted: 07/07/2021] [Indexed: 11/24/2022] Open
Abstract
As a traditional Chinese medicine, Patrinia scabiosifolia Link has been used to treat various inflammatory-related diseases, and recent studies have shown that it possesses potent anti-inflammatory activity. Therefore, phytochemical investigation on whole plants of P. scabiosifolia were carried out, which led to the isolation of two new iridoid glucosides, patriniscabiosides A (1) and B (2), together with six known compounds (3–8). The structural elucidation of all compounds was performed by HRESIMS and extensive spectroscopic analyses including IR, 1D, 2D NMR, and electronic circular dichroism (ECD). All the isolated compounds were tested for their anti-inflammatory activity using the NF-κB-Dependent Reporter Gene Expression Assay, and compound 3 displayed anti-inflammatory activity through the inhibition of the NF-κB pathway, with an inhibitory rate of 73.44% at a concentration of 10 μM.
Collapse
|
4
|
Gong L, Zou W, Zheng K, Shi B, Liu M. The Herba Patriniae (Caprifoliaceae): A review on traditional uses, phytochemistry, pharmacology and quality control. JOURNAL OF ETHNOPHARMACOLOGY 2021; 265:113264. [PMID: 32846192 PMCID: PMC7443212 DOI: 10.1016/j.jep.2020.113264] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Revised: 07/21/2020] [Accepted: 08/06/2020] [Indexed: 05/11/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Herba Patriniae has been used for thousands of years in China as a traditional Chinese medicine with heat-clearing and detoxicating effects. It is applied widly for the treatment of rheumatoid arthritis, diarrhea, acute hepatitis, pelvic inflammatory disease and ulcerative colitis in clinic. Two species, namely Patrinia scabiosaefolia Fisch. (PS) and Patrinia villosa Juss. (PV) from the Caprifoliaceae family, are considered as Herba Patriniae in the pharmaceutical industry. AIM OF THE REVIEW This paper aims to comprehensively outline the traditional uses, botanical description, phytochemistry, pharmacology, toxicology, quality control, pharmacokinetics and patents of Herba Patriniae, and elaborate the same/different characteristics between PS and PV. MATERIALS AND METHODS Detailed information of Herba Patriniae was collected from various online databases (Pubmed, Web of Science, Google Schola, China National Knowledge Infrastructure Database, National Intellectual Property Administration, PRC National Medical Products Administration), and those published resources (M.Sc. Thesis and books). RESULTS A total of 233 compounds have been identified in Herba Patriniae, including triterpenoid saponins, flavonoids, organic acids, iridoids, and volatiles. A very distinct difference was observed, that PS is rich in triterpenoid saponins and volatiles, while PV contains more flavonoids. Two source species of Herba Patriniae gave similar pharmacological effects on anti-cancer, anti-inflammatory, antioxidant, antimicrobial, sedative and hypnotic effects. But there were no reports were on antipruritic, proangiogenic and anti-diarrheal effects for PS, and no studies on anti-diabetic effects for PV. Generally, Herba Patriniae showed non-toxic in the clinical dose, but mild side effects, such as temporary leukopenia, dizziness and nausea, could be found when large and excessive dosage is used. A variety of compounds have been quantified for the quality control of PS and PV. The variety, growth environment, growth time, and harvest time not only affected the contents but also the pharmacological activities of the bioactive compounds. In the past year, patents for compositions containing PV and PS have been filed, mainly involving human health, hygiene, agriculture, and animal husbandry. Unfortunately, the research on pharmacokinetics is insufficient. Only the prototype components and metabolites were repored after intragastric administration of total flavonoids extract from PV in rats. CONCLUSION Herba Patriniae has displayed a significant medicinal value in clinic, but the differences in phytochemistry, pharmacological effects and the content of compounds have been found between two official recorded species. About side effects and pharmacokinetic characteristics, the differences between two species have not been well studied. For a better clinical use of Herba Patriniae, it is urgent to establish systematic pharmacology, quality control, pharmacokinetics, and clinical researches on the same/different characteristics between PS and PV.
Collapse
Affiliation(s)
- Linna Gong
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
| | - Wei Zou
- NHC Key Laboratory of Birth Defects Research, Prevention and Treatment, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, 410008, China.
| | - Keyang Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
| | - Birui Shi
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
| | - Menghua Liu
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
| |
Collapse
|
5
|
Liu Y, Liu W, Wang J, Liu Y, Chen C, Xiang Z. Phytochemical and Pharmacological Review on Two Herbs of Baijiangcao: Patrinia scabiosaefolia Fisch. ex Trev. and Patrinia villosa (Thunb.) Juss. MINI-REV ORG CHEM 2020. [DOI: 10.2174/1570193x16666190617161124] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Patrinia scabiosaefolia Fisch. Trev. and Patrinia villosa (Thunb.) Juss, are two species of
Patrinia recorded in the Chinese Pharmacopoeia with the same Chinese name “Baijiangcao” and similar
therapeutic effect in traditional Chinese medicine. The present article is the first comprehensive
review on the chemical composition and pharmacological activities of these herbs. In this review, data
on chemical constituents and pharmacological profile of the two herbs are provided. This review
discusses all the classes of the 223 compounds (phenylpropanoids, flavonoids, terpenes, saponins and
volatile components, etc.) detected in the two herbs providing information on the current state of
knowledge of the phytochemicals present in them. In the past three years, our research group has isolated
and identified about more than 100 ingredients from the two herbs. Therefore, we published a
systematic review of our research papers and studies on the two herbs were carried out using resources
such as classic books about Chinese herbal medicine and scientific databases including Pubmed,
Web of Science, SciFinder, CNKI. etc. The present review discusses the most thoroughly studied
pharmacological activities (antioxidant, anti-inflammatory, immunomodulatory, antimicrobial,
antitumor and antiviral activities) of the two herbs. This comprehensive review will be informative
for scientists searching for new properties of these herbs and will be important and significant for the
discovery of bioactive compounds from the two herbs and in complete utilization of Patrinia scabiosaefolia
Fisch. ex Trev. and Patrinia villosa (Thunb.) Juss.
Collapse
Affiliation(s)
- Yangcheng Liu
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| | - Wei Liu
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| | - Jiaqi Wang
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| | - Yang Liu
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| | - Changlan Chen
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| | - Zheng Xiang
- School of Pharmaceutical Science, Liaoning University, Shenyang, China
| |
Collapse
|
6
|
He X, Luan F, Zhao Z, Ning N, Li M, Jin L, Chang Y, Zhang Q, Wu N, Huang L. The Genus Patrinia: A Review of Traditional Uses, Phytochemical and Pharmacological Studies. THE AMERICAN JOURNAL OF CHINESE MEDICINE 2017; 45:637-666. [PMID: 28595500 DOI: 10.1142/s0192415x17500379] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The aim of the present review is to comprehensively outline the botanical description, traditional uses, phytochemistry, pharmacology and toxicology of Patrinia, and to discuss possible trends for the further study of medicinal plants from the genus Patrinia. The genus Patrinia plays an important role in Asian medicine for the treatment of erysipelas, conjunctival congestion with swelling and pain, peri-appendicular abscesses, lung carbuncle, dysentery, leucorrhea, and postpartum disease. More than 210 chemical constituents have been isolated and identified from Patrinia plants, especially P. scabiosaefolia Fisch., P. scabra Bunge, P. villosa Juss., P. heterophylla Bunge and P. rupestris(Pall.) Juss[Formula: see text] Of these compounds, triterpenoids and saponins, iridoids, flavonoids, and lignans are the major or active constituents. Both in vitro and in vivo studies have indicated that some monomer compounds and crude extracts from the genus Patrinia possess wide pharmacological activities, including antitumor, anti-inflammatory, antibacterial, and antiviral effects. In addition, they have been shown to have valuable and positive effects on the immune and nervous system in experimental animals. There are also some reports on the clinical uses and toxicity of these species. However, few reports have been published concerning the material identification or quality control of Patrinia species, and the clinical uses and toxic effects of these plants are relatively sparse. More attention must be given to these issues.
Collapse
Affiliation(s)
- Xirui He
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Fei Luan
- Department of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China
- Department of Pharmacy, Xi’an Weiyang District Hospital of Traditional Chinese Medicine, Xi’an, 710016, P. R. China
| | - Zefeng Zhao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Ning Ning
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| | - Maoxing Li
- Department of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China
- Department of Pharmacy, Lanzhou General Hospital of PLA, Key Laboratory of the Prevention and Treatment for Injury in Plateau of PLA, Lanzhou 730050, P. R. China
| | - Ling Jin
- Department of Pharmacy, Xi’an Weiyang District Hospital of Traditional Chinese Medicine, Xi’an, 710016, P. R. China
| | - Yu Chang
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| | - Qiang Zhang
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Ni Wu
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Linhong Huang
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| |
Collapse
|
7
|
Metabolomic Study on the Preventive Effect of Patrinia scabiosaefolia Fisch on Multipathogen Induced Pelvic Inflammatory Disease in Rats. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2015; 2015:170792. [PMID: 26175792 PMCID: PMC4484566 DOI: 10.1155/2015/170792] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/14/2015] [Revised: 04/09/2015] [Accepted: 04/24/2015] [Indexed: 02/07/2023]
Abstract
Patrinia
scabiosaefolia Fisch (PSF), a well-known traditional Chinese medicine (TCM), has been used as a “heat-clearing and detoxifying” agent. The present study was to illustrate the preventive effect of PSF on pelvic inflammatory disease (PID) in rats. The PID model was constructed by multipathogen infection of the upper genital tract with reference to the method previously reported. Urine metabolomic analysis was conducted with a GC-MS coupled with derivatization method. In this study, PID rats showed obvious infiltration of inflammatory cells and elevated expression of cytokines (IL-1β and IL-6) in upper genital tract, compared with control rats. Sixteen differentiating metabolites contributed to the alteration of metabolic profile in PID rats, including two amino acids, three fat acids, nine organic acids, and two types of sugars. The rats, infected by multipathogen and administered with PSF, showed decreased infiltration of inflammatory cells and lowered expression of cytokines in upper genital tract, compared with PID rats. Meanwhile, PSF intervened in the PID-associated alterations in TCA cycle, sugar metabolism, amino acid metabolism, and other uncertain metabolic pathways. These results indicate that PSF has preventive effect on multipathogen induced PID and holistic interventional effect on disease-associated metabolomic change.
Collapse
|
8
|
Lee EJ, Kim C, Kim JY, Kim SM, Nam D, Jang HJ, Kim SH, Shim BS, Ahn KS, Choi SH, Jung SH, Ahn KS. Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction ofPatrinia scabiosaefoliathrough suppression of NF-κB activation in RAW 264.7 cells. Immunopharmacol Immunotoxicol 2011; 34:282-91. [DOI: 10.3109/08923973.2011.602412] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
9
|
|
10
|
|
11
|
Chiu LCM, Ho TS, Wong EYL, Ooi VEC. Ethyl acetate extract of Patrinia scabiosaefolia downregulates anti-apoptotic Bcl-2/Bcl-X(L) expression, and induces apoptosis in human breast carcinoma MCF-7 cells independent of caspase-9 activation. JOURNAL OF ETHNOPHARMACOLOGY 2006; 105:263-8. [PMID: 16361073 DOI: 10.1016/j.jep.2005.11.007] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/28/2005] [Revised: 10/27/2005] [Accepted: 11/14/2005] [Indexed: 05/05/2023]
Abstract
Patrinia scabiosaefolia Fisch. is a Chinese medicinal herb used traditionally for treating intestinal carbuncle. Although Patrinia scabiosaefolia has also been suggested for cancer therapy, there has not been any scientific evidence supporting this application. In this study, a panel of human cancer cells, including breast carcinoma MCF-7; hepatocellular carcinoma HepG2; skin melanoma A375; lung carcinoma A549 and prostate adenocarcinoma PC-3, were treated in vitro with ethyl acetate extract of Patrinia scabiosaefolia (EAE-PS) for 48 h. Results from MTT study showed that MCF-7 was the most responsive (IC50 = 112.3 microg/ml) while PC-3 was the most resistant (IC50 = 348.7 microg/ml) one to cell growth inhibition. DNA flow cytometry demonstrated that EAE-PS induced apoptosis in the resistant MCF-7 cells by 14.5-fold of the control level after 36 h of treatment. Immunoblot studies further illustrated that although EAE-PS downregulated the anti-apoptotic Bcl-2/Bcl-X(L) expression in breast cancer cells, the induced apoptosis could not be prevented by the caspase-9 inhibitor (Z-LEHD-FMK). All these results suggest that EAE-PS retards MCF-7 cell growth by activating the caspase-independent mitochondrial cell death pathway. Results from this study support future research and development of the bioactive ingredients from Patrinia scabiosaefolia as anticancer agents, especially against those apoptosis-resistant cancers with deregulated Bcl-2/Bcl-X(L) expression.
Collapse
Affiliation(s)
- Lawrence C-M Chiu
- Department of Biology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
| | | | | | | |
Collapse
|